Physician profile
Aaron Smith
NPI 1689124802
$1,612.56
in general payments reported to CMS, 2019-2025
11 companies · $784 in 2025
The $784 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.01 · 2022: $95.76 · 2023: $76.39 · 2024: $593 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,221.82 | 2023-2025 | Mako, Gamma, Insignia |
| Smith+Nephew, INC. | $104.00 | 2022-2025 | Pico 14, Renasys Touch, "Acticoat 4"" X 4""" |
| Heron Therapeutics, INC. | $57.09 | 2024 | Zynrelef |
| Cerapedics INC. | $42.23 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Ethicon US, LLC | $39.43 | 2021 | |
| Ferring Pharmaceuticals INC. | $34.24 | 2023 | Euflexxa |
| Orthofix Medical, INC. | $30.76 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $30.24 | 2024-2025 | Exparel, Iovera, Zilretta |
| Globus Medical, INC. | $24.58 | 2021 | |
| Endo Pharmaceuticals INC. | $15.42 | 2023 | Xiaflex |
| Depuy Synthes Sales INC. | $12.75 | 2023 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.